株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

重症急性呼吸器症候群(SARS)コロナウイルス感染症:世界の治験レビュー

Severe Acute Respiratory Syndrome (SARS) Global Clinical Trials Review, H2, 2016

発行 GlobalData 商品コード 322154
出版日 ページ情報 英文 35 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.77円で換算しております。

2016年12月31日まで 年末キャンペーン割引: GlobalData社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
重症急性呼吸器症候群(SARS)コロナウイルス感染症:世界の治験レビュー Severe Acute Respiratory Syndrome (SARS) Global Clinical Trials Review, H2, 2016
出版日: 2016年09月30日 ページ情報: 英文 35 Pages
概要

当レポートでは、重症急性呼吸器症候群(SARS)コロナウイルス感染症の臨床試験に関連する基本情報やデータを提供しており、試験件数および被験者の募集状況、段階別の動向、臨床試験を実施している主な製薬企業および研究機関のプロファイルなどをまとめています。

イントロダクション

  • 重症急性呼吸器症候群(SARS)コロナウイルス感染症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州の主要国における治験件数
    • 北米の主要国における治験件数

G7諸国での治験件数:感染症の治験における重症急性呼吸器症候群(SARS)コロナウイルス感染症の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:感染症の治験における重症急性呼吸器症候群(SARS)コロナウイルス感染症の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

重症急性呼吸器症候群(SARS)コロナウイルス感染症治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • Pharmstandard
    • Hemispherx Biopharma, Inc.
  • 代表的な研究機関・病院の治験の概要
    • The National Institute of Allergy and Infectious Diseases
    • National Taiwan University Hospital
    • Queen Mary Hospital
    • Hospital Authority
    • Queen's University

5つの代表的な治験のプロファイル

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC3828CTIDB

GlobalData's clinical trial report, "Severe Acute Respiratory Syndrome (SARS) Global Clinical Trials Review, H2, 2016" provides an overview of Severe Acute Respiratory Syndrome (SARS) clinical trials scenario. This report provides top line data relating to the clinical trials on Severe Acute Respiratory Syndrome (SARS). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Severe Acute Respiratory Syndrome (SARS) to Infectious Disease Clinical Trials
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Severe Acute Respiratory Syndrome (SARS) to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Severe Acute Respiratory Syndrome (SARS) Therapeutics Clinical Trials
  • Latest Clinical Trials News on Severe Acute Respiratory Syndrome (SARS)
    • Aug 24, 2016: Experts at World Congress of Internal Medicines Reinforce Importance of BETADINE in Disease Prevention, Infection Control and Oral Mucositis Treatment
    • Aug 08, 2016: GeneOne Life Science Announces Full Enrollment of First-In-Human Study of MERS Vaccine
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Severe Acute Respiratory Syndrome (SARS) Therapeutics, Global, Clinical Trials by Region, 2016*
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016*
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics Clinical Trials, Europe, Top Countries, 2016*
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Proportion of Severe Acute Respiratory Syndrome (SARS) to Infectious Disease Clinical Trials, G7 Countries (%), 2016*
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Severe Acute Respiratory Syndrome (SARS) to Infectious Disease Clinical Trials, E7 Countries (%), 2016*
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*

List of Figures

  • Severe Acute Respiratory Syndrome (SARS) Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016*
  • Proportion of Severe Acute Respiratory Syndrome (SARS) to Infectious Disease Clinical Trials, G7 Countries (%), 2016*
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Severe Acute Respiratory Syndrome (SARS) to Infectious Disease Clinical Trials, E7 Countries (%), 2016*
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Severe Acute Respiratory Syndrome (SARS) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • GlobalData Methodology
Back to Top